Core Viewpoint - The company, Baotou Huazi Industrial Co., Ltd., plans to establish a wholly-owned subsidiary, Baotou Henglu Biotechnology Co., Ltd., with an investment of 10 million yuan to enhance its product offerings and support its strategic development goals [2][3][11]. Group 1: Investment Overview - The investment amount for the establishment of the subsidiary is 10 million yuan [3]. - The subsidiary will be fully funded by the company, with 100% ownership [5][9]. - The establishment of the subsidiary aligns with the company's strategy of "innovation-driven, diversified layout, and promoting industrial upgrading" [5][11]. Group 2: Company Strategy and Product Development - The new subsidiary will focus on developing skincare products using xanthan gum and convenient nutritional meal replacement products using resistant dextrin [5][11]. - The subsidiary will leverage existing research and development platforms, including collaborations with academic institutions, to explore advancements in the health industry [6][11]. Group 3: Decision and Approval Process - The decision to establish the subsidiary was approved unanimously by the board of directors during a meeting held on December 18, 2025 [6][18]. - The investment does not require shareholder approval and is within the board's decision-making authority [4][7]. Group 4: Impact on the Company - The investment is expected to enhance the company's product value chain and extend its industrial chain [11]. - The funding for the investment will be sourced from the company's own funds, ensuring no adverse impact on the company's financial status [11][12].

Core Viewpoint - The company Huazi Industrial (600191) announced the establishment of a wholly-owned subsidiary, Baotou Henglu Biotechnology Co., Ltd., with a registered capital of 10 million yuan to advance its development strategy of "innovation-driven, diversified layout, and promoting industrial upgrading" [1] Group 1: Company Strategy - The establishment of the new subsidiary aims to enhance the company's product offerings and extend its industrial chain [1] - The company currently produces products such as xanthan gum and resistant dextrin, which are key components in various applications [1] Group 2: Product Development - The new subsidiary will focus on developing skincare products using xanthan gum, an important additive in cosmetics [1] - The company plans to launch convenient nutritional meal replacement products, including weight loss meal replacement powder and nutritional beverages, utilizing resistant dextrin, which is a soluble dietary fiber [1] - The development of these new products is expected to help the company increase its product value chain [1]

Core Viewpoint - The company plans to establish a wholly-owned subsidiary, Baotou Henglu Biotechnology Co., Ltd., with a registered capital of 10 million yuan to advance its development strategy of "innovation-driven, diversified layout, and promoting industrial upgrading" [1] Group 1: Company Strategy - The establishment of the subsidiary aims to enhance the company's product offerings, including xanthan gum and resistant dextrin, which are crucial for the development of skincare products and convenient nutritional meal replacements [1] - The new products will help the company extend its industrial chain and improve its product value chain [1] Group 2: Technological Collaboration - The subsidiary will leverage existing resources such as the Baotou Huazi Synthetic Biology and Microbial Modification Technology Academician Workstation and the collaborative "Technology Demonstration Base" with the Chinese Academy of Sciences [1] - The company plans to work closely with industry experts, scholars, and research institutions to track cutting-edge technologies and industry trends in biological fermentation and health products [1]

Core Viewpoint - The company plans to establish a wholly-owned subsidiary, Baotou Henglu Biotechnology Co., Ltd., with a registered capital of 10 million yuan to advance its development strategy of "innovation-driven, diversified layout, and promoting industrial upgrading" [1] Group 1: Company Strategy - The establishment of the new subsidiary aims to enhance the company's product offerings, including the development of skincare products using xanthan gum and convenient nutritional meal replacement products utilizing resistant dextrin [1] - The new product development is expected to extend the company's industrial chain and enhance the value chain of its products [1] Group 2: Technological Collaboration - The subsidiary will leverage existing resources such as the Baotou Huazi Synthetic Biology and Microbial Modification Technology Academician Workstation and the collaborative "Technology Demonstration Base" and "Co-Creation Base" with the Chinese Academy of Sciences [1] - The company plans to collaborate with industry experts, scholars, and research institutions to stay updated on cutting-edge technologies and industry trends in biological fermentation and health products [1]

Core Viewpoint - The company plans to establish a wholly-owned subsidiary, Baotou Henglu Biotechnology Co., Ltd., with a registered capital of 10 million yuan, to advance its development strategy of "innovation-driven, diversified layout, and promoting industrial upgrading" [1] Group 1: Company Strategy - The establishment of the new subsidiary aims to enhance the company's product offerings, including the development of skincare products using xanthan gum, an important additive in cosmetics [1] - The subsidiary will also focus on launching convenient nutritional meal replacement products, such as weight loss meal replacement powder and nutritional beverages, utilizing resistant dextrin, a soluble dietary fiber [1] - The development of these new products is expected to help the company extend its industrial chain and enhance its product value chain [1] Group 2: Technological Collaboration - The new subsidiary will leverage existing resources, including the Baotou Huazi Synthetic Biology and Microbial Modification Technology Academician Workstation, and collaborate with the Chinese Academy of Sciences' Environmental Biotechnology Key Laboratory to establish technology demonstration and co-creation bases [1] - The company plans to work closely with industry experts, scholars, and research institutions to monitor cutting-edge technologies and industry trends in biological fermentation and health products [1] - This initiative aligns with the company's strategic planning for industrial upgrading and development in the health industry [1]